share_log

HC Wainwright & Co. Upgrades Alaunos Therapeutics to Buy, Announces $1.5 Price Target

HC Wainwright & Co. Upgrades Alaunos Therapeutics to Buy, Announces $1.5 Price Target

HC Wainwright & Co.將Alaunos Therapeutics升級爲買入,宣佈目標股價爲1.5美元
Benzinga ·  2023/05/15 19:21

HC Wainwright & Co. analyst Swayampakula Ramakanth upgrades Alaunos Therapeutics (NASDAQ:TCRT) from Neutral to Buy and announces $1.5 price target.

HC Wainwright & Co. 分析師Swayampakula Ramakanth將Alaunos Therapeutics(納斯達克股票代碼:TCRT)從中性上調至買入,並宣佈了1.5美元的目標股價。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論